Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous stem cell company treating those who suffer in ...
Newron Pharmaceuticals notes new publication highlighting clinically meaningful benefits of evenamide as an adjunctive treatment in schizophrenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results